Medication info
Empamax Tablet 10 mg (Empagliflozin L-Proline)

Empamax Tablet 10 mg (Empagliflozin L-Proline)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin L-Proline›12.55mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Light yellow, convex on both sides with rounded edges, film-coated tablet
Packaging
30 tablets/box [10 tablets/ptp x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 202107167 · Approved 2021.10.27 · Insurance code 643309700

Summary

Main use
Treatment of type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease
Who takes it
Adults
Adult dose
Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine should be administered in combination with other standard therapies for chronic kidney disease. Type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. This medicine should not be used in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of treatment with this medicine is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease

  • Type 2 diabetes
  • blood sugar control abnormalities
  • chronic heart failure
  • cardiovascular disease
  • chronic kidney disease
View approved original text

This drug is used in conjunction with diet and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It is also used with other medications to reduce the risk of death and hospitalization from cardiovascular disease in patients with chronic heart failure. In adult patients with chronic kidney disease, it helps lower the risk of kidney function deterioration and cardiovascular death. Overall, this drug is effective in improving the health of patients with diabetes, heart failure, and kidney disease.

How to take

Adult dose

Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine should be administered in combination with other standard therapies for chronic kidney disease. Type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. This medicine should not be used in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of treatment with this medicine is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered (see Precautions, 4. General Precautions).

Precautions

This drug should not be used by patients who have an allergic reaction to the active ingredient, patients with type 1 diabetes, or those with diabetic ketoacidosis. Patients with decreased kidney function should use this drug cautiously and should have their kidney function tested before and regularly during use. It is especially not recommended for patients with very low kidney function or those on dialysis. When used in conjunction with insulin or medications that promote insulin secretion, the risk of hypoglycemia may increase; therefore, dosage adjustments of these medications may be necessary when used together with this drug. This drug may cause side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, and decreased fluid volume, so symptoms should be monitored closely. Ensure immediate medical consultation if symptoms like vomiting, abdominal pain, or difficulty breathing occur due to the risk of serious metabolic diseases known as ketoacidosis. Elderly patients and those at risk of fluid loss should be cautious about dehydration and hypotension, and it is important to regularly check blood pressure and fluid status. Cases of liver damage have been reported with this drug, so caution is needed in patients with liver function abnormalities. Additionally, this drug can cause serious urinary infections such as urosepsis or pyelonephritis, so immediate treatment is necessary if symptoms of urinary infections occur. It is recommended that pregnant women not use this drug, and breastfeeding should be discontinued during treatment with this drug. Pediatric and adolescent patients (under 18 years) should not use this drug as its safety and efficacy have not been established. Caution is necessary when driving or operating machinery due to the risk of hypoglycemia during treatment with this drug. No specific toxic symptoms have been reported in the event of overdose, but if overdose is suspected, immediate medical attention should be sought. Lastly, this drug should be kept out of the reach of children and not transferred to other containers.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • constipation
  • pruritus
  • rash
  • urticaria
  • angioedema
  • decreased fluid volume
  • increased urination
  • urinary difficulty
Show 215 more
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vaginitis
  • vulvitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic hemorrhage
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stones
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • colorectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • unstable angina
  • upper abdominal pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyps
  • gingival edema
  • passage of bloody stool
  • hemorrhoids
  • pancreatic cysts
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory decrease
  • perception disorder
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensation
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • electrocardiogram abnormality
  • hemoglobin decrease
  • hemoglobin increase
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary tract pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • reduced appetite
  • obesity
  • snoring
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliolumbar ligament syndrome
  • open eye injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular disorder
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorder
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to avoid exposure to light or air. It is also recommended to store at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, convex on both sides with rounded edges, film-coated tablet

Package unit

30 tablets/box [10 tablets/ptp x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.